Drug Overview Fasenra (benralizumab; AstraZeneca/Kyowa Hakko Kirin) is a humanized monoclonal antibody which binds to the alpha chain of the interleukin (IL)-5 receptor on eosinophils and therefore depletes them. Elevated eosinophils are related to the cause and severity of asthma, as well as to asthma exacerbations. This mechanism of action differs from Nucala (mepolizumab; GlaxoSmithKline) and Cinqair (reslizumab; Teva), which bind to the IL-5 ligand, and this is proposed to lead to a faster onset of action.
Our reports have been used by over 10K customers, including:
Leiomyosarcoma Disease - Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Leiomyosarcoma Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Leiomyosarcoma Clinical trials scenario. This report provides top line data relating to the clinical trials on...
200 pages •
By The Business Research Company
• Dec 2020
Major players in the adalimumab, infliximab and etanercept biosimilars market are Zydus Cadila, Sandoz (Novartis), Samsung Bioepis, AbbVie, Amgen, Boehringer Ingelheim, Pfizer, Celltrion and Mylan. The global adalimumab, infliximab, and etanercept market is expected to grow from $2.2 billion in 2019 to $2.27 billion in 2020 at a compound...
Mycosis Fungoides Disease - Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Mycosis Fungoides Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Mycosis Fungoides Clinical trials scenario. This report provides top line data relating to the clinical...
Small Intestine Cancer Disease - Global Clinical Trials Review H2 2020 Summary clinical trial report, “Small Intestine Cancer Disease - Global Clinical Trials Review, H2 2020" provides an overview of Small Intestine Cancer Clinical trials scenario.This report provides top line data relating to the...
Vasculitis Disease - Global Clinical Trials Review, H2 2020 Summary clinical trial report, “Vasculitis Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Vasculitis Clinical trials scenario.This report provides top line data relating to the clinical trials on Vasculitis. Report...
200 pages •
By The Business Research Company
• Dec 2020
Major players in the arthritis monoclonal antibodies market are Johnson & Johnson, Roche, Novartis, Pfizer Inc, AbbVie Inc., Amgen Inc., Genentech, GSK, AstraZeneca PLC, and Mylan N.V. The global arthritis monoclonal antibodies market is expected to decline from $46.48 billion in 2019 to $45.18 billion in 2020 at a compound annual growth...
200 pages •
By The Business Research Company
• Dec 2020
Major players in the cancer monoclonal antibodies market are Amgen, Bristol Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Genmab AS, GlaxoSmithKline, Johnson & Johnson, Novartis AG, Merck & Co., and Spectrum Pharmaceuticals. The global cancer monoclonal antibodies market is expected to decline from $48.36 billion...
200 pages •
By The Business Research Company
• Dec 2020
Major players in the breast cancer monoclonal antibodies (mAbs) market are Amgen, Mylan, Merck, Novartis, GlaxoSmithKline, Daiichi Sankyo, Biocad, Boehringer Ingelheim, Bristol-Myers Squibb, and Array BioPharma. The global breast cancer monoclonal antibodies market is expected to decline from $13.57 billion in 2019 to $12.60 billion...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.